[74] Gastrointestinal effects could include nausea, dyspepsia, and increased risk of peptic ulceration, particularly with concurrent use of other ulcerogenic medications
The FTO gene variant rs9939609 and the GLP1R gene variant rs6923761 affect how rapidly your body responds to semaglutide signaling
Its incidence is increasing [25], probably because of the use of VPA in psychiatric disorders
Jaiswal M, Martin CL, Brown MB, Callaghan B, Albers JW, Feldman EL, Pop-Busui R (2015) Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes
Compared with similar people who didnt take GLP-1 medications, those who did had about a 50% higher risk of being diagnosed with the condition